860575P

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0)

Avanti Research^™ - A Croda Brand 860575P, powder

• 別名: D-lactosyl-β1-1′-N-octanoyl-L-threo-sphingosine
• 実験式（ヒル表記法）: C₃₈H₇₁NO₁₃
• CAS番号: 939036-94-9
• 分子量: 749.97
• MDL番号: MFCD28143570
• UNSPSCコード: 12352211
• NACRES: NA.25

特性

• フォーム: powder
• 包装: pkg of 1 × 1 mg (860575P-1mg)
• メーカー／製品名: Avanti Research^™ - A Croda Brand 860575P
• 脂質タイプ: sphingolipids
• 輸送温度: dry ice
• 保管温度: −20°C
• SMILES記法: CCCCCCCCCCCCC/C=C/[C@@](O)([H])[C@@]([H])(NC(CCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O[C@H](O2)[C@H](O)[C@@H](O)[C@H]([C@H]2CO)O
• InChI Key: JUCWRRXMPGRQOG-CKTHHAJGSA-N

詳細

詳細

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) is a synthetic glycosphingolipid (GSL) with nonnatural stereochemistry.

アプリケーション

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) may be used to disrupt brain-derived neurotropic factor (BDNF)-induced integrin clustering.

生物化学的／生理学的作用

C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) is a caveolar uptake inhibitor, which blocks SV40 virus infection. It also prevents E1-integrin activation and downstream signaling. C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0) can deter the aggregation of lipids and proteins into glycosphingolipids (GSLs) and cholesterol-enriched microdomains (rafts) at the plasma membrane (PM).

包装

5 mL Amber Glass Screw Cap Vial (860575P-1mg)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3